ORIGINAL PAPER
Analysis of blood count derivative parameters and selected biochemical and fibrinolysis parameters in children with urticaria
 
More details
Hide details
1
Katedra i Klinika Pediatrii, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny, Katowice, Polska
 
 
Submission date: 2022-06-30
 
 
Final revision date: 2022-07-22
 
 
Acceptance date: 2022-07-22
 
 
Publication date: 2022-12-30
 
 
Pediatr Pol 2022;97(4):311-318
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Urticaria is a common disease in the pediatric population. It is characterized by the presence of wheals, angioedema or coexistence of these changes. The pathomechanism of urticaria is associated with activation of the immune system, development of inflammation and changes in the coagulation system. The aim of the study was to analyze selected blood count parameters and their derivatives (neutrophil/lymphocyte ratio – NLR, platelet/lymphocyte ratio – PLR, mean platelet volume/platelet count ratio – MPR), C-reactive protein (CRP) and D-dimers in children with acute urticaria (AU) and chronic urticaria (CU) to assess their suitability for predicting the occurrence and activity of the disease.

Material and methods:
We performed a retrospective analysis of the clinical data and selected laboratory results in 125 children with urticaria (76 with AU and 49 with CU) hospitalized in our center between 2013 and 2019. The control group consisted of 75 healthy children.

Results:
Based on logistic regression analysis, we recorded an increased risk of AU and CU occurrence in the case of elevated NLR, neutrophil count, white blood cells (WBC), CRP and D-dimer values. Statistical analysis revealed that the best predictor of urticaria development was an increase in D-dimers (area under the curve –AUC = 0.84, sensitivity 86%, specificity 69%, cut-off 390.0). In patients with AU the disease activity was positively correlated with CRP (r = 0.24, p = 0.04) and D-dimer levels (r = 0.28, p = 0.02). In CU there was a positive correlation between disease activity and NLR (r = 0.44, p < 0.001), WBC (r = 0.30, p = 0.04) and CRP values (r = 0.35, p = 0.01).

Conclusions:
Increased CRP, WBC, NLR, platelet and D-dimer levels reflect the activation of inflammation and fibrynolysis present in urticaria. Further studies are required to determine the utility of these parameters as biomarkers of urticaria activity in children.
REFERENCES (38)
1.
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international ACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022; 77: 734-766.
 
2.
Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children – a systematic review on interventions and comorbidities. Pediatr Allergy Immunol 2018; 29: 303-310.
 
3.
Shin M, Lee S. Prevalence and causes of childhood urticaria. Allergy Asthma Immunol Res 2017; 9: 189-190.
 
4.
Czarnecka-Operacz M, Szulczyńska-Gabor J, Leśniewska K, et al. Acute-phase response and its biomarkers in acute and chronic urticaria. Postepy Dermatol Alergol 2018; 35: 400-407.
 
5.
Papadopoulos J, Karpouzis A, Tentes J, Kouskoukis C. Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria. J Clin Med Res 2014; 6: 133-137.
 
6.
Machura E, Szczepańska M, Mazur B, Barć-Czarnecka M, Kasperska- Zając A. Interleukin 1-β, interleukin-1 receptor antagonist, and interleukin 18 in children with acute spontaneous urticaria. Biomed Res Int 2013; 2013: 605262.
 
7.
Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: an updated review of the pathogenesis and management. Pediatr Allergy Immunol 2019; 30: 17-24.
 
8.
Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A. Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up. J Am Acad Dermatol 2018; 79: 599-614.
 
9.
Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5: 10.
 
10.
Góra A, Jaszczura M, Morawiecka-Pietrzak M, Kleszyk M, Machu- ra E. What do we currently know about urticaria in children? Pediatr Pol 2022; 97: 133-139.
 
11.
Comert S, Celebioglu E, Karakaya G, Kalyoncu AF. The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria. Allergol Immunopathol (Madr) 2013; 41: 239-245.
 
12.
Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol 2014; 28: 469-474.
 
13.
Asero R, Tedeschi A, Marzano AV, Cugno M. Chronic urticaria: a focus on pathogenesis. F1000Res 2017; 11: 1095.
 
14.
Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV. Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 2012; 10: 653-658.
 
15.
Grzanka R, Damasiewicz-Bodzek A, Kasperska-Zajac A. Interplay between acute phase response and coagulation/fibrinolysis in chronic spontaneous urticaria. Allergy Asthma Clin Immunol 2018; 14: 27.
 
16.
Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr 2019; 45: 101.
 
17.
Peng W, Li C, Zhu WJ, et al. Prognostic value of the platelet to lymphocyte ratio change in liver cancer. J Surg Res 2015; 194: 464-470.
 
18.
Paliogiannis P, Satta R, Deligia G, et al. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med 2019; 19: 37-45.
 
19.
Yim JH, Park HJ, Cho SY, Shin MK. Mean platelet volume and mean platelet volume/platelet count ratio in chronic urticaria. Ann Dermatol 2019; 31: 467-469.
 
20.
Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed) 2020; 16: 255-261.
 
21.
Jaszczura M, Góra A, Grzywna-Rozenek E, Barć-Czarnecka M, Machura E. Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol Int 2019; 39: 869-878.
 
22.
Lorette G, Giannetti A, Pereira RS, Leynadier F, Murrieta-Aguttes M. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group. J Eur Acad Dermatol Venereol 2000;14: 83-90.
 
23.
Karaman S, Turedi B. Neutrophil-lymphocyte ratio: a possible marker of remission in children with chronic spontaneous urticaria. Allergol Immunopathol (Madr) 2020; 48: 290-294.
 
24.
Akelma AZ, Mete E, Cizmeci MN, Kanburoglu MK, Malli DD, Bozkaya D. The role of mean platelet volume as an inflammatory marker in children with chronic spontaneous urticaria. Allergol Immunopathol (Madr) 2015; 43: 10-13.
 
25.
Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011; 41: 1386-1391.
 
26.
Giménez-Arnau AM, DeMontojoye L, Asero R, et al. The pathogenesis of chronic spontaneous urticaria: the role of infiltrating cells. J Allergy Clin Immunol Pract 2021; 9: 2195-2208.
 
27.
Li Y, Wang W, Yang F, Xu Y, Feng C, Zhao Y. The regulatory roles of neutrophils in adaptive immunity. Cell Commun Signal 2019; 17: 147.
 
28.
Jiang Y, Ma W. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in atopic dermatitis patients. Med Sci Monit 2017; 23: 1340-1346.
 
29.
Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician 2015; 92: 1004-1011.
 
30.
Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm 2019; 2019: 9213074.
 
31.
Kasperska-Zając A, Grzanka A, Jarzab J, et al. The association between platelet count and acute phase response in chronic spontaneous urticaria. Biomed Res Int 2014; 2014: 650913.
 
32.
Farres MN, Refaat M, Melek NA, Ahmed EE, Shamseldine MG, Arafa NA. Activation of coagulation in chronic urticaria in relation to disease severity and activity. Allergol Immunopathol (Madr) 2015; 43: 162-167.
 
33.
Kolkhir P, André F, Church MK, Maurer M, Metz M. Potential blood biomarkers in chronic spontaneous urticaria. Clin Exp Allergy 2017; 47: 19-36.
 
34.
Zaryczański J, Ochab A, Ochab M, Zaryczańska A, Brzoza Z, Chobot A. D-dimer concentrations in acute urticaria in children. Allergol Immunopathol (Madr) 2021; 49: 107-112.
 
35.
Zhang Y, Zhang H, Du S, Yan S, Zeng J. Advanced biomarkers: therapeutic and diagnostic targets in urticaria. Int Arch Allergy Immunol 2021; 182: 917-931.
 
36.
Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-1117.
 
37.
Kolkhir P, Altrichter S, Hawro T, Maurer M. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria. Allergy 2018; 73: 940-948.
 
38.
Asero R. Serial D-dimer plasma levels in a patient with chronic spontaneous urticaria developing resistance to omalizumab. Clin Exp Dermatol 2017; 42: 667-669.
 
Journals System - logo
Scroll to top